Endovascular procedures for aorto-iliac occlusive disease are associated with superior short-term clinical and economic outcomes compared with open surgery in the inpatient population  by Indes, Jeffrey E. et al.
From the Society for Clinical Vascular Surgery
Endovascular procedures for aorto-iliac occlusive
disease are associated with superior short-term
clinical and economic outcomes compared with
open surgery in the inpatient population
Jeffrey E. Indes, MD, Anant Mandawat, BS, Charles T. Tuggle, BS, Bart Muhs, MD, PhD, and
Julie A. Sosa, MD, New Haven, Conn
Objectives: There has been a rapid increase in the number of endovascular procedures performed for peripheral artery
disease, and especially aorto-iliac occlusive disease (AIOD). Results from single-center reports suggest a benefit for
endovascular procedures; however, these benefits may not reflect general practice. We used a population-based analysis to
determine predictors of clinical and economic outcomes following open and endovascular procedures for inpatients with
AIOD.
Methods: All patients with AIOD who underwent open and endovascular procedures in the Healthcare Cost and
Utilization Project Nationwide Inpatient Sample, 2004 to 2007, were identified. Independent patient- and provider-
related characteristics were analyzed. Clinical outcomes included complications and mortality; economic outcomes
included length of stay (LOS) and cost (2007 dollars). Outcomes were compared using 2, ANOVA, and multivariate
regression analysis.
Results: Four thousand, one hundred nineteen patients with AIODwere identified. Endovascular procedures increased by
18%. Patients who underwent endovascular procedures were more likely to be>65 years of age (46% vs 37%), female (54%
vs 49%), and in the highest quartile of household income (20% vs 16%), all P < .05. Endovascular patients were more
likely to be non-elective (41% vs 20%), in the highest comorbidity index group (8% vs 5%), and with iliac artery disease
(67% vs 33%), all P < .05. In bivariate analysis, endovascular procedures were associated with lower complication rates
(16% vs 25%), shorter LOS (2.2 vs 5.8 days), and lower hospital costs ($13,661 vs $17,161), all P< .001. In multivariate
analysis, endovascular procedures had significantly lower complication rates and cost, and shorter LOS.
Conclusions: Endovascular procedures have superior short-term clinical and economic outcomes compared with open
procedures for the treatment of AIOD in the inpatient setting. Further studies are needed to examine long-term outcomes
and access-related issues. ( J Vasc Surg 2010;52:1173-9.)The prevalence of peripheral artery disease (PAD) in-
creases dramatically with age, rising from 6% in patients 38
to 59 years of age, to 16% in patients 60 to 69 years of age,
to 34% in patients70 years of age.1 Patients with PAD are
three times more likely to die when compared with
matched controls.1 Aorto-iliac occlusive disease (AIOD)
reduces quality of life based on assessments of pain, social
functioning, and mental health.2
Treatment options for AIOD include open repair (end-
arterectomy, bypass, and extra-anatomic bypass) and per-
cutaneous endovascular interventions (angioplasty and/or
stenting), with an ongoing debate regarding which cases
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doi:10.1016/j.jvs.2010.05.100benefit most from a given approach.3-6 Patency rates re-
lated to angioplasty and stenting techniques vary, but ap-
proach 81% and 64% at 4 and 5 years, respectively.7,8
Aorto-bifemoral bypass (AFB) is more invasive than endo-
vascular techniques, but is still considered the more durable
“gold standard” treatment, with a 5-year patency rate of
85%. Extra-anatomic bypasses have a lower 5-year patency
rate, but may be more appropriate in certain patient types.7
Previous studies have shown that inpatients with AIOD
have improved outcomes following endovascular repair
based on in-hospital mortality, length of stay (LOS), and
total hospital charges, but these studies used data nearly a
decade old.9 Currently, many vascular specialists will first
offer AIOD patients an endovascular treatment option, if
possible. Many patients are now treated as outpatients for
AIOD using endovascular techniques; however, these are
usually patients with less severe forms of the disease and fewer
comorbidities. The Trans-Atlantic Inter-Society Consensus
Document on Management of Peripheral Arterial Disease
(TASC), published in January 2000,10 and the TASC II,
published in 2007,11 recommended open surgery for
TASC II D lesions and endovascular procedures for TASC
II A lesions. Choice of treatment for TASC II B and C
lesions was left up to the discretion of the surgeon.
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compare contemporary short-term clinical and economic
outcomes following open and endovascular procedures for
inpatients with AIOD, and to identify predictors of supe-
rior outcome.
METHODS
Data source. We conducted a cross-sectional analysis of
2004 to 2007 hospital discharge information from the
Healthcare Cost and Utilization Project Nationwide Inpa-
tient Sample (HCUP-NIS) database, a 20% stratified sample
of inpatient admissions from acute care hospitals maintained
by the Agency for Healthcare Research and Quality.12
HCUP-NIS is the largest all-payer inpatient database in the
United States, with approximately eight million hospital
stays per year. The most recent years available were used.
International Classification of Diseases (ICD-9) codes for
diagnoses of AIOD and procedures related to direct open
and endovascular repair were used to abstract patients40
years of age. AIOD was initially identified using a principal
diagnosis of atherosclerosis of the aorta (440.0), arterial
embolism and thrombosis of abdominal aorta (444.0), or
arterial embolism and thrombosis of iliac artery (444.81;
Appendix; online only). Patients with the following diag-
noses were excluded to limit the analysis to AIOD: reno-
vascular hypertension (405.01, 405.11, 405.91), renal ar-
tery atherosclerosis (440.1), renal artery thrombosis/
occlusion (593.81), chronic vascular insufficiency of the
intestine – mesenteric (557.1), embolism and/or throm-
bosis of upper extremity (444.21), arterial embolism or
thrombosis-femoral, peripheral, NOS, popliteal (444.22).
Cases were divided into open or endovascular groups based
on principal procedure. A surgical approach to treatment
included aorto-iliac-femoral bypass (39.25), endarterec-
tomy of the aorta (38.14), endarterectomy of abdominal
arteries (38.16), and femoral-femoral/axillo-femoral by-
pass (39.29). An endovascular procedure was considered to
be an interventional approach to treatmentwhen using angio-
plasty or atherectomy of non-coronary vessel(s) (39.50) or
insertion of non-drug-eluting peripheral vessel stent(s)
(39.90). Patients receiving both endovascular and open
procedures in the same hospitalization were excluded from
analysis.
Independent demographic variables included calendar
year, patient age (40-64, 65 years of age), gender, race
(White, Black, Hispanic, and other, which included but was
not limited to Asians, Pacific Islanders, and Native Ameri-
cans), median household income (quartiles), admission
type (elective vs non-elective), and principal diagnosis.
Patient comorbidity was measured using the enhanced
Charlson Comorbidity Index.13,14
Independent hospital-provider variables included hos-
pital region (Northeast, Midwest, South, West), hospital
location (urban vs rural), and teaching status (teaching vs
non-teaching).
Outcome variables. Primary outcomes of interest
were 1) in-hospital patient complications, 2) in-hospital
patient mortality, 3) mean LOS, and 4) total inpatienthospital costs. Postoperative complications were catego-
rized as cardiovascular, respiratory, infection/device/graft-
related, or other (including neurologic, gastroenterology/
urology-related, and incisional). Acute post-hemorrhagic
anemia (285.1) was only included as a complication if a
concurrent diagnosis of transfusion (99.00, 99.01, 99.02,
99.03) was present. Paralytic ileus (560.1) was not in-
cluded as a complication but is reported separately. Com-
plications were treated as a binomial outcome (complica-
tion vs no complication). Specific complications having an
n 11 patients per category were in compliance with
confidentiality standards set forth by HCUP and are re-
ported. Mean LOS and total inpatient hospital cost were
log-transformed to achieve a more normal distribution.
Total inpatient costs were calculated using the HCUP-NIS
adjusted, hospital-group average cost-to-charge ratios.
Costs were then adjusted for inflation, converting all costs
to 2007 dollars, using rates from the Bureau of Labor
Statistics.15
Data analysis. Bivariate analysis of independent vari-
ables by outcomes was performed using 2 statistical
analysis for categorical variables and analysis of variance
(ANOVA) for continuous variables. Multivariate linear re-
gressionmodels were used to adjust for significant indepen-
dent variables for LOS and total inpatient costs. Multivar-
iate logistic regression models were used to adjust for
in-hospital patient complications and in-hospital patient
mortality. All probability values are the results of two-sided
tests, and P  .05 is reported as significant. Data analysis
and management were performed using SPSS version 16.0
(Chicago, IL). This study was deemed exempt at our
institution from Institutional Review Board approval, as
HCUP-NIS is a public database with no personal identify-
ing information.
RESULTS
Patient demographics. Over the study period of
2004 to 2007, 4119 patients underwent procedures for
AIOD in the HCUP-NIS. There were 1100 patients
treated with endovascular interventions and 3019 patients
treated with open repair. There were more women in the
endovascular group (Table I). More patients in the 65
age group received endovascular interventions, along with
patients in the highest quartile of household income. There
was no significant difference in race between treatment
groups. Urgent procedures were managed more often with
an endovascular approach; open procedures were far more
common in the elective setting. Patients with disease of the
iliac arteries were more often treated with an endovascular
approach, while patients with aortic disease were more
likely to be treated with an open intervention.
In-hospital complications and mortality. The over-
all in-hospital complication rate was 16% in the endovascu-
lar group and 25% in the open group (P  .001; Fig 1).
However, there was no significant difference in mortality
rates between the endovascular (1.8%) and open (2.5%)
treatment groups. Complications that were more likely to
occur with open surgery included cardiac arrest during the
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hemorrhagic anemia with transfusion, all respiratory compli-
cations, postoperative and device-related infections, oliguria,
and wound seroma, all P  .05 (grouped complication rates
reported in Table II). Reportable specific complication
rates included (endovascular vs open) hematoma compli-
cating procedure (4.4% vs 1.4%, respectively), acute post-
hemorrhagic anemia with transfusion (1.8% vs 6.7%), acute
respiratory failure (1.2% vs 3.5%), and pneumonia, organ-
Table I. Characteristics of patients with AIOD
undergoing open and endovascular procedures, HCUP-
NIS 2004-2007 (N  4119)
Characteristics
Endovascular
(n  1100)
Open
(n  3019)
P value% %
Demographics
Gender .05
Female 54 49
Age (yrs) .001
40-64 54 63
65 46 37
Race NS
White 83 85
Black 8 8
Hispanic 5 4
Other 4 3
Clinical
Admission type .001
Non-elective 41 20
Elective 59 80
Charlson Index .05
None 15 16
Low 55 56
Moderate 22 23
High 8 5
Diagnosis .001
Aortic disease 33 67
Iliac artery disease 67 33
NS, Not significant.
Fig 1. Unadjusted complications and mortality for patients with
aorto-iliac occlusive disease (AIOD), by procedure type.ism unspecified (1.0% vs 3.0%), all P  .05. Althoughparalytic ileus was not considered a complication, it was
highly associated with open as compared with endovascular
procedures (8.6% vs 1.0%; P  .001). Hematoma was the
only complication associated with increased incidence fol-
lowing endovascular repair (P  .001).
Unadjusted clinical and economic outcomes. In-
dependent demographic and clinical variables for patients
undergoing open and endovascular procedures that were
significantly associated with in-hospital complications in-
cluded patient age, gender, admission type, Charlson Index
group, AIOD diagnostic classification, and procedure type
(Table III). Female patients had a higher incidence of
complications than men (24.7% vs 20.9%, respectively; P
.01). The rate of complications increased with age (20.3%
in 40-64 group, 26.6% in 65 group; P  .001). Urgent
admissions also were associated with a higher incidence of
complications as compared to elective cases (27.6% vs
21.2%, P .001). As Charlson Index severity increased, so
too did the rate of complications (no comorbidities 15.3%,
low score 21.9%, moderate score 27.4%, high score 34.3%;
P  .001). Patients with aortic disease had higher compli-
cation rates (27.6%) than patients with iliac artery disease
(16.3%; P  .001).
Patient age, admission type, Charlson Index group, and
diagnosis were associated with mortality during the hospi-
talization. Mortality increased with age (1.1% in the 40-64
group, and 4.1% in the 65 group; P  .001), and it was
higher for urgent compared to elective admissions (4.6% vs
1.5%; P  .001). Mortality increased as Charlson Index
severity increased (no comorbidities 1.6%, low score 1.7%,
moderate score 3.4%, high score 5.2%; P  .001). Patients
with aortic disease had a higher mortality rate than those with
iliac artery disease (3.0% vs 1.4%, respectively; P .001).
Patients undergoing endovascular interventions had an
average LOS of 2.2 days, while those undergoing open
repair had an average LOS of 5.8 days (P  .001; Fig 2).
Total inpatient cost was $13,661 for endovascular repair,
and $17,161 for open repair (P  .001).
Adjusted clinical and economic outcomes. All pa-
tient and provider characteristics associated with our out-
comes on bivariate analyses were initially included in mul-
tivariate regression analyses. Patient age 65 years, non-
elective admission, higher Charlson Index, aortic disease,
and undergoing an open procedure were independently
associated with a higher complication rate (all P  .01;
Table IV). Characteristics associated with a significantly
higher mortality rate were age 65 years, non-elective
admission, and a diagnosis of aortic disease (all P 
.001).
Factors associated with increased LOS included female
gender, non-elective admission, increased Charlson Index
severity, aortic disease, and undergoing an open procedure
(all P  .05; Table V). Patient age 65, non-elective
admission, increased Charlson Index severity, aortic dis-
ease, undergoing an open procedure, and hospital location
in the West were associated with an increase in total inpa-
tient cost (all P .05). Factors associated with a lower total
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DISCUSSION
Upchurch et al in 2004 documented increased utiliza-
tion of percutaneous angioplasty and stenting for the treat-
ment of AIOD from 1996 up to 2000. Compared with
angioplasty and stenting, AFB was associated with a higher
mortality rate (3.7% vs 1.9%; P  .001) and increased
LOS.9 Based on the largest single-center experience to
date, AFB has an overall 5% perioperative mortality rate.16
Primary patency at 3 years is significantly higher for AFB
than for angioplasty and stenting. However, secondary
patency, limb salvage, and mortality appear equal, making
endovascular repair a viable alternative to open treatment.4
With only minor exceptions, endovascular surgery has not
appreciably increased the complexity of redo open aortic
operations performed for AIOD.17
Despite these important results, there are no current
population-based studies analyzing AIOD outcomes, and re-
sults are limited to single center experiences. We used a
population-based analysis to determine contemporary short-
term clinical and economic outcomes following open and
endovascular procedures for inpatients with AIOD. There
were significantly higher rates of cardiac, respiratory, geni-
Table II. In-hospital complications for patients with AIO
HCUP-NIS 2004-2007 (N  4119)
Complication
Cardiac/vascular/bleeding/embolic
Arrest during or resulting from procedure
Postop shock
Hemorrhage complicating procedure
Hematoma complicating procedure
Accidental puncture/laceration
Acute post-hemorrhagic anemia with transfusion
Atheroembolism of lower extremity
Respiratory
Respiratory complication
Acute respiratory failure
Pneumonia, organism unspecified
Pulmonary insufficiency following surgery, acute respiratory
distress syndrome
Infection – device or graft related
Other postop infection
Infection due to vascular device/implant/graft
Complication due to vascular device/implant/graft
Mechanical complication of vascular device/implant/graft
Other
Iatrogenic cerebrovascular infarction/hemorrhage
Postop stroke
Oliguria/anuria
Acute renal failure
Urinary tract infection
Seroma complicating procedure
Postop incisional hernia
NS, Not significant.tourinary, incisional, and infectious complications in pa-tients who underwent open repair. A higher mortality rate
also was observed in our open treatment group, but this did
not reach statistical significance. Age 65 years, increased
comorbidity, and undergoing an open procedure led to a
higher incidence of complications after adjusting for other
significant independent predictors. Advanced age, urgent
admission, and a diagnosis of aortic disease led to a higher
adjusted mortality. We found a significantly shorter LOS
for patients receiving endovascular treatment, and it was
less costly than open repair. A separate analysis excluding
extra-anatomic bypasses from the open group gave us sim-
ilar outcomes.
The increased utilization of catheter-based techniques
has made it possible for endovascular specialists to treat
severely diseased patients who might not otherwise tolerate
open procedures. In a study by Knipp et al analyzing trends
between 1998 and 2001, a 73% decrease in combined open
aortic and renal revascularizations, and a 56% decrease in
isolated open renal revascularizations occurred. Catheter-
based procedures increased by 173% during this same pe-
riod. Predictors favoring utilization of catheter-based treat-
ment were admission acuity, increasing patient age, non-
White race, and high socioeconomic status.18 In our study,
inpatients undergoing endovascular procedures were more
likely to be65 years and have more associated comorbidi-
dergoing open and endovascular procedures,
CD-9 code
Endovascular
(n  1100)
Open
(n  3019)
P value% %
8.9 13.1 .001
997.1
998.0
998.11
998.12
998.2
285.1
445.02
2.3 12.4 .001
997.3
518.81
486
518.5
3.5 4.0 NS
998.59
996.62
996.74
996.1
5.3 6.7 NS
997.02
997.09
997.5
584.9
599.0
998.13
553.21D un
Ities. This observation also has been made in other stud-
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endovascular repair generally were older, more likely to
smoke, have hyperlipidemia, and have undergone prior
Table III. Unadjusted clinical outcomes for patients
with AIOD undergoing open and endovascular
procedures, HCUP-NIS 2004-2007 (N  4119)
Characteristics
Complications Mortality
% P value % P value
Demographics
Gender .01 NS
Male 20.9 1.9
Female 24.7 2.7
Age .001 .001
40-64 20.3 1.1
65 26.6 4.1
Race NS NS
White 22.8
†
Black 22.0
†
Hispanic 23.6
†
Other 27.2
†
Clinical
Admission type .001 .001
Non-elective 27.6 4.6
Elective 21.2 1.5
Charlson Index .001 .001
None 15.3 1.6
Low 21.9 1.7
Moderate 27.4 3.4
High 34.3 5.2
Diagnosis .001 .001
Aortic disease 27.6 3.0
Iliac artery disease 16.3 1.4
Procedure type .001 NS
Endovascular 16.3 1.8
Open 25.2 2.5
NS, Not significant.
†n too small to report per Agency for Healthcare Research and Quality data
use agreement.
Fig 2. Unadjusted length of stay (LOS) and cost for patients with
aorto-iliac occlusive disease (AIOD), by procedure type.endovascular interventions. They also observed a non-significant trend toward lower mortality in patients treated
with endovascular interventions. These findings, along
with our observation that there was a trend toward signifi-
cance in increased complications following open repair,
suggest that patients be counseled about this possible risk
during the informed consent process.
Recent single center experiences have shown no signif-
icant difference in the rates of complications following
endovascular and open treatment for AIOD.4,8 These stud-
ies focused primarily on patency rates, and limited analyses
of complications related to open and endovascular treat-
ment were done. Kashyap et al had the most extensive
analysis of perioperative complications and showed no dif-
ference between the two treatment types in rates of myo-
cardial infarction, respiratory failure, wound infection, ex-
tremity ischemia/thrombosis, or renal failure. These results
largely reflect outcomes at centers with high volumes of
patients with AIOD, and therefore with particular expertise
in their management. In contrast, our findings represent
population-level outcomes associated with all hospital
types, and suggest that patients who undergo open repair
have a higher rate of complications. Hematoma was the
exception, in that it was more likely to occur in patients
undergoing endovascular repair; presumably these bleeds
were access-related. A higher hematoma rate also was ob-
served when percutaneous endovascular procedures were
compared with open repair for the treatment of renal artery
stenosis, but this has not been described previously for
AIOD.19
Those patients in our data set with a low, moderate,
and high comorbidity index were at significantly increased
risk of developing a complication. Our results suggest that
patients with AIOD and increased complexity of illness are
better served with endovascular treatment. Despite the
better patency rates associated with AFB, long-term sur-
Table IV. Adjusted clinical outcomes from open and
endovascular procedures for AIOD, HCUP-NIS
2004-2007 (N  4119)
Explanatory variable Odds ratio (CI) P value
Complications
Age 65 yrs 1.45 (1.24-1.69) .001
Non-elective admission 1.68 (1.42-2.00) .001
Charlson Index
None — —
Low 1.47 (1.16-1.87) .01
Moderate 1.78 (1.37-2.32) .001
High 2.54 (1.78-3.62) .001
Aortic disease 1.84 (1.56-2.18) .001
Open procedure 1.73 (1.42-2.11) .001
Mortality
Age 65 yrs 4.04 (2.57-6.34) .001
Non-elective admission 3.56 (2.34-5.43) .001
Aortic disease 3.11 (1.92-5.03) .001
CI, 95% confidence interval.
Reference groups: age 40-64 yrs, elective admission, Charlson Index: none,
iliac artery disease, endovascular procedure.vival appears equal between patients receiving open and
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series by Timuran et al. Cumulative patient survival was
similar between the two groups. Smoking history and hy-
perlipidemia were the only independent predictors of de-
creased long-term survival in multivariate analyses.8 Just as
recent studies have shown that endovascular treatment is
better for high-risk patients with abdominal aortic aneu-
rysms (AAAs), it may be safer to offer high-risk patients
with AIOD angioplasty and stenting as first line treat-
ment.20-22
To date, therapeutic decisions have been based widely
on results from institutional series and case reports. An
advantage of administrative databases such as HCUP-NIS
is that patient outcomes after vascular procedures across the
country can be determined.23 It is important to consider
these outcomes when deciding on a treatment plan. For
example, Birkmeyer et al demonstrated that implementa-
tion of Leapfrog provider volume standards could aid em-
ployers and health care purchasers to improve outcomes for
high-risk vascular and oncologic procedures.24
It is important to include cost considerations when
weighing whether a new technology should be adopted as
part of the routine treatment paradigm. New devices asso-
ciated with endovascular treatment can be costly; for exam-
Table V. Adjusted economic outcomes from open and
endovascular procedures for AIOD, HCUP-NIS 2004-
2007 (N  4119)
Explanatory variable  Coefficient (CI) P value
LOS
Constant 2.30 (2.16-2.45) —
Gender: female 0.23 (0.09-0.39) .001
Non-elective admission 1.84 (1.59-2.11) .001
Charlson Index
None — —
Low 0.21 (0.01-0.43) .05
Moderate 0.58 (0.32-0.85) .001
High 1.50 (1.05-2.01) .001
Aortic disease 1.31 (1.11-1.53) .001
Open procedure 4.50 (4.11-4.94) .001
Year: 2007 0.37 (0.53 to 0.19) .001
Cost
Constant 10,146 (9110-11,301) —
Age 65 yrs 889 (366-1551) .001
Non-elective admission 3598 (2617-4808) .001
Charlson Index
None — —
Low 701 (62-1529) .05
Moderate 1602 (721-2740) .001
High 4493 (2651-6923) .001
Aortic disease 4327 (3304-5573) .001
Open procedure 2628 (1779-3685) .001
Hospital region
South 1160 (1502 to 687) .001
West 1731 (794-2943) .001
Urban hospital 914 (1418 to 220) .05
CI, 95% confidence interval.
Reference groups: male gender, age 40-64 yrs, elective admission, Charlson
Index: none, iliac artery disease, endovascular procedure, year 2004, hospital
region: Northeast, rural hospital.ple, an iliac stent (Luminexx; Bard, Tempe, Ariz) is nearlythree times the cost of a bifurcated dacron AFB graft (W.L.
Gore, Flagstaff, Ariz). However, in our analysis, endovas-
cular therapy was less costly than open repair. This trend
also has been observed comparing endovascular and open
AAA repair, likely due to benefits associated with endovas-
cular repair in terms of reduction in morbidity and mortal-
ity, as well as reduced LOS.25 Using data from a decade
ago, Upchurch et al observed opposite findings, when AFB
was less expensive than endovascular repair.9 This change in
the direction of the cost difference between open and
endovascular treatments for AIOD represents a novel ob-
servation, and has important implications in the current
health care reform environment, where policy makers, pa-
tients, providers, and insurers are paying special attention
to cost-containment.
Limitations of this study include those inherent to any
study using an administrative database. Patient anatomy
and AIOD severity, based on preoperative imaging, are not
available in HCUP-NIS; rationale for treatment selection
and outcomes based on TASC/TASC II classification are
unknown. Indications for treatment such as claudication,
rest pain, and tissue loss cannot be determined. In addition,
ICD-9 coding does not perfectly differentiate acute condi-
tions such as a “saddle embolus” from chronic total occlu-
sion of the aorta; the former usually has a much greater
severity of illness. Errors in coding and documentation are
a possibility, although they have been shown to be lim-
ited.26 We cannot determine from HCUP-NIS whether
open cases were done due to endovascular failure, or vice
versa; however, we excluded patients if both procedures
were coded in order to eliminate the possible effect of a
cross-over in treatment strategy. Also, endovascular pa-
tients treated in the outpatient setting are not captured. To
get a sense of the proportion of endovascular cases done as
outpatients at the population level, we separately identified
cases in the Florida State inpatient (SID) and ambulatory
surgery (SASD) databases for 2005 to 2006. In 2005, 41%
and in 2006, 43% of endovascular procedures for AIOD
were performed in the outpatient setting. No open cases
were done in the outpatient setting (data not shown). We
focused on inpatients with AIOD, who likely have more
severe AIOD and complexity of illness than those treated in
the ambulatory setting. Therefore, it is particularly striking
that endovascular interventions apppear to afford superior
short-term clinical and economic outcomes in this complex
subset of patients. Inpatient hospitalizations including 23-
hour observation stays may not be consistently reported by
all participating institutions. Information on each patient is
limited to a single hospitalization, and longitudinal analysis
with review of long-term outcomes such as rates of read-
mission, survival, and patency could not be measured.
Endovascular treatment for AIOD appears to be more
suitable than open repair for higher-risk patients who are
older, with more comorbid conditions, and who require
urgent treatment for their AIOD in the inpatient setting. It
is independently associated with lower complication rates,
shorter length of stay, and lower inpatient costs. Future
study is needed to measure whether short-term outcome
JOURNAL OF VASCULAR SURGERY
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patency rates and patient survival.
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procedure codes
ICD-9 Diagnosis
440.0 Atherosclerosis of the aorta
444.0 Arterial embolism and thrombosis of abdominal aorta
444.81 Arterial embolism and thrombosis of iliac artery
Procedure
Open
38.14 Endarterectomy of the aorta
38.16 Endarterectomy of abdominal arteries
39.25 Aorta-iliac-femoral bypass
39.29 Axillo-femoral bypass, femoral-femoral bypass
Endovascular
39.50 Angioplasty or atherectomy of other non-coronary
vessel(s)
